SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-011906
Filing Date
2019-08-08
Accepted
2019-08-08 16:16:52
Documents
85
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 790487
2 ex31-1.htm EX-31.1 18286
3 ex31-2.htm EX-31.2 18046
4 ex32-1.htm EX-32.2 9699
  Complete submission text file 0001493152-19-011906.txt   6289124

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE btx-20190630.xml EX-101.INS 1161961
6 XBRL SCHEMA FILE btx-20190630.xsd EX-101.SCH 76729
7 XBRL CALCULATION FILE btx-20190630_cal.xml EX-101.CAL 92885
8 XBRL DEFINITION FILE btx-20190630_def.xml EX-101.DEF 422588
9 XBRL LABEL FILE btx-20190630_lab.xml EX-101.LAB 514112
10 XBRL PRESENTATION FILE btx-20190630_pre.xml EX-101.PRE 460573
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 5105213390
BIOTIME INC (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 191009758
SIC: 2836 Biological Products, (No Diagnostic Substances)